Cardiac Hydatid Cyst Successfully Managed with Albendazole: A Case Report

Reem A AlShamlan1, Abdulrahman M Almousa2, Mohammed J Al Saeed1

  • 1Family and Community Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU.

Cureus
|January 24, 2020
PubMed

Insights

Hydatid disease, a parasitic infection, rarely affects the heart. A young girl with a history of kidney cysts developed a cardiac hydatid cyst, which significantly improved with albendazole treatment.

Area of Science:

  • Parasitology
  • Cardiology
  • Infectious Diseases

Background:

  • Hydatid disease, caused by *Echinococcus* tapeworms, is globally distributed and can affect various organs.
  • Cardiac involvement in hydatid disease is exceptionally rare, posing diagnostic and therapeutic challenges.

Observation:

  • A young female patient presented with chest pain and dyspnea.
  • She had a prior history of a surgically treated renal hydatid cyst.

Findings:

  • Diagnostic investigations revealed a hydatid cyst within the left ventricular wall.
  • Medical management with albendazole resulted in a dramatic clinical improvement.

Implications:

  • This case underscores the necessity of considering hydatid disease in patients with a history of parasitic cysts, even with cardiac symptoms.
  • Early suspicion and appropriate treatment, including medical therapy, are crucial for managing rare cardiac manifestations of hydatidosis.

Related Concept Videos

Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...